Literature DB >> 7827878

Molecular and cellular basis of cancer invasion and metastasis: implications for treatment.

W G Jiang1, M C Puntis, M B Hallett.   

Abstract

In the past decade significant advances in establishing the underlying biological mechanisms of tumour invasion and metastasis have been made. Some of the triggering factors and genes relevant to metastatic spread have been identified. Advances have also been made in understanding the signal transduction pathways involved in invasion and metastasis. This increased comprehension of the malignant metastatic process has enabled new antimetastatic strategies to be devised. This review summarizes progress in these areas and discusses the implications for the treatment of metastasis.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7827878     DOI： 10.1002/bjs.1800811107

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


  30 in total

Review 1.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

2.  Survivin is a potential mediator of prostate cancer metastasis.

Authors:  Min Zhang; John J Coen; Yoshiyuki Suzuki; Michael R Siedow; Andrzej Niemierko; Li-Yan Khor; Alan Pollack; Yifen Zhang; Anthony L Zietman; William U Shipley; Arnab Chakravarti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-16       Impact factor: 7.038

3.  Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.

Authors:  L C van Kempen; J J van den Oord; G N van Muijen; U H Weidle; H P Bloemers; G W Swart
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.

Authors:  R K Chiu; A Droll; D L Cooper; S T Dougherty; J F Dirks; G J Dougherty
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

5.  Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.

Authors:  Sayyed Farshid Moussavi-Harami; Kari B Wisinski; David J Beebe
Journal:  J Patient Cent Res Rev       Date:  2014

6.  Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumours: comparison of different methods of assessing vascularity.

Authors:  N A Wong; J Willott; M J Kendall; E A Sheffield
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

7.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.

Authors:  W G Jian; S J Darnton; K Jenner; L J Billingham; H R Matthews
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

8.  Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma.

Authors:  Zhong-Qiu Wang; Jie-Shou Li; Guang-Ming Lu; Xin-Hua Zhang; Zi-Qian Chen; Kui Meng
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  Single cell adhesion measuring apparatus (SCAMA): application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression.

Authors:  Christopher P Palmer; Maria E Mycielska; Hakan Burcu; Kareem Osman; Timothy Collins; Rachel Beckerman; Rebecca Perrett; Helen Johnson; Ebru Aydar; Mustafa B A Djamgoz
Journal:  Eur Biophys J       Date:  2007-09-19       Impact factor: 1.733

Review 10.  Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Authors:  Lilly Y W Bourguignon
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.